Aglaia BioMedical Ventures combines its focus on oncology with disciplined financing and a hands-on involvement – up to the level of strategic and operational management – to ensure focus on value creation and capital efficiency: keys to success for early stage companies. New additions to our team should bring complimentary scientific as well as clinical, legal, financial and business development expertise to the company.
If you are interested in joining a dynamic, fast-moving company, which will offer great experience in any of the areas you are suited for, please send us your details and a resumé at email@example.com.
Modra Pharmaceuticals Announces Start of Phase II Study for its Lead Oral Chemotherapy in Patients with Metastatic Prostate Cancer
Inthera Bioscience raises CHF 10.5 million in Series A financing round